Drug Development Solutions

  1. Co-Crystal Prediction Service 11/4/2025

    AI-driven co-crystal prediction accelerates solubility optimization by identifying ideal co-formers in days without needing the drug substance. Learn how to save time, reduce costs, and boost formulation success.

  2. Cell Culture Media For Viral Vector Applications 11/3/2025

    Explore media solutions for viral vector production that support HEK293 and insect cells, with custom development, analytical testing, and scalable preparation tools to optimize performance.

  3. Patient-Centric Solutions: Taste Masking 6/14/2021

    Taste, smell, and mouthfeel are the key product features to address when developing pediatric formulations. Incremental formulation and clinical research require cost-effective solutions with flexibility in manufacturing scale.

  4. From Sequence To Clinic: Faster Decisions Through In Silico Insights 1/21/2026

    In‑silico modeling enables early prediction of molecule stability, formulatability, and risks, reducing lab work, guiding candidate selection, and supporting efficient drug‑product development from sequence to clinic.

  5. Meeting The Unique Needs Of Your Sterile Injectable With Exact SI-ence

    Explore how a CDMO with dedicated quality and analytical teams, robust processes, and specialized technologies can help support your sterile injectable product from clinical to commercial.

  6. Cleanroom Capabilities And Expertise

    Learn how the right partner can ensure that your facilities maintain cGMP-compliance and help establish the correct testing program and parameters based on your needs.

  7. Microbiology Testing: Health Inspired, Quality Driven 4/22/2024

    Whether driven by regulatory mandates or the need to maintain sterility, our services can assist you in meeting these requirements efficiently and accurately, thereby safeguarding patient well-being.

  8. Testing Solutions For Biosimilars 4/22/2024

    Our scientists offer insights into physicochemical and structural properties, including post-translational modifications, through a range of assays.

  9. End-to-End Services In Vaccines, CGTs, And Biologics 7/25/2023

    IDT Biologika provides end-to-end services in contract development and manufacturing of vaccines, cell and gene therapeutics, and fill/finish of biologics.

  10. Multiparticulates For Modified Release Systems 1/12/2026

    Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.